• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

adhd medications for adults Medication During Pregnancy and Breastfeeding

Women suffering from ADHD face a difficult decision regarding whether or not to stop taking ADHD medication during pregnancy and breastfeeding. There is a lack of information about how long-term exposure to these medications may affect the fetus.

A study recently published in Molecular Psychiatry shows that children exposed to ADHD medication during utero do not develop neurological disorders like impaired vision or hearing seizures, febrile seizures, or IQ impairment. The authors acknowledge the need for higher-quality research.

Risk/Benefit Analysis

Pregnant women who take ADHD medications need to balance the advantages of taking them against potential risks to the foetus. Physicians don't have the data to give clear advice, but can provide information on the risks and benefits to help pregnant women make informed decisions.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have a significantly higher risk of fetal cardiac malformations or major birth defects that are structural. Researchers conducted a large population-based case-control study to evaluate the incidence of major structural birth defects in infants born to mothers who had taken stimulants in the early stages of pregnancy and those who had not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure an accurate classification of the cases and to reduce the possibility of bias.

However, the study was not without its flaws. The most important issue was that they were unable to distinguish the effects of the medication from the effects of the disorder at hand. That limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to the use of medication or comorbidities that cause confusion. Additionally, the researchers did not look at long-term offspring outcomes.

The study found that infants whose mother had taken ADHD medication during pregnancy were at a slightly higher risk of admission to the neonatal care unit (NICU) as compared to those whose mothers did not use any medication during pregnancy or had discontinued taking their medication prior to or during pregnancy. This increase was due to central nervous system-related disorders and the increased risk for admission was not found to be influenced by which stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have a caesarean section or a baby that scored low on the Apgar scale (less than 7). These risks did not appear to be affected by the kind of medication used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the higher benefit for both mother and child of continued treatment for the woman's condition. Physicians should discuss the issue with their patients and, if possible, assist them in developing strategies for improving their coping skills which can reduce the impact of her disorder on her daily life and relationships.

Medication Interactions

Doctors are increasingly confronted with the dilemma of whether to maintain treatment or stop it during pregnancy as more women are diagnosed with ADHD. These decisions are usually taken without clear and authoritative evidence. Instead, doctors have to weigh their own knowledge, the experience of other physicians and the research that has been conducted on the subject.

The issue of risk to infants is difficult to determine. The research that has been conducted on this topic is based on observations rather than controlled studies and the results are contradictory. Furthermore, most studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects that could result in abortion or termination of the pregnancy. The study presented in the journal club addresses these limitations by analyzing both information on deceased and live births.

Conclusion Some studies have shown an association between ADHD medications and certain birth defects However, other studies haven't shown such a relationship. Most studies show that there is a neutral, or slightly negative, effect. Therefore, a careful risk/benefit assessment must be conducted in every situation.

For women suffering from ADHD and ADD, the decision to discontinue medication is difficult if not impossible. In a recent article in Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of loneliness. In addition, a decrease in medication may affect the ability to do jobs and drive safely that are crucial aspects of daily life for many people suffering from ADHD.

She suggests that women who are unsure about whether to continue or stop taking medication because of their pregnancy, consider educating family members, friends, and coworkers on the condition, its impact on daily functioning, and the advantages of continuing the current treatment plan. It can also help a woman feel more confident in her decision. Some medications can pass through the placenta. If a patient decides to stop taking her ADHD medication while breastfeeding, it is crucial to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about what impact the medications could have on the fetuses. A recent study published in the journal Molecular Psychiatry adds to the body of knowledge about this subject. With two massive data sets researchers were able look at more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. While the overall risk is low, the researchers found that exposure in the first trimester to adhd treatment medication medications was associated with an increased risk of specific heart defects, like ventriculo-septal defects (VSD).

The authors of the study didn't discover any connection between early medication usage and congenital anomalies like facial deformities or club feet. The results are in line with previous studies showing a small but significant increase in the risk of developing cardiac malformations among women who began taking ADHD medications prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their medication given for adhd.

Women who took best adhd medication for women medications in the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score following delivery, and a baby who needed breathing assistance at birth. The researchers of the study could not eliminate selection bias because they limited the study to women with no other medical conditions that might have contributed to the findings.

Researchers hope that their study will provide doctors with information when they see pregnant women. They suggest that although the discussion of the benefits and risks is important, the decision to stop or maintain treatment should be based on each woman's requirements and the severity of her ADHD symptoms.

The authors caution that, while stopping the medication is a possibility to think about, it isn't recommended due to the high rate depression and other mental disorders among women who are pregnant or have recently given birth. Furthermore, research suggests that women who decide to stop taking their medication are more likely to have a difficult time adjusting to life without them after the birth of their baby.

Nursing

It can be a stressful experience to become a mother. Women who suffer from ADHD may face a lot of challenges when they must deal with their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to new routines. Many women opt to continue taking their ADHD medication during pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medications is absorbed through breast milk at low levels. However, the rate of exposure to medication by the newborn may differ based on dosage, frequency it is taken and the time of the day the medication is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract or non stimulant adhd medication through breast milk. The effect on the health of a newborn is not fully comprehended.

Some physicians may discontinue stimulant medications during a woman's pregnancy due to the absence of research. This is a complicated decision for the patient, who must weigh the benefit of continuing her medication with the potential dangers to the fetus. As long as there is no more information, GPs should ask all pregnant patients about their history of intuniv adhd medication and if they are planning or taking to take medication during the perinatal period.

Numerous studies have demonstrated that women can continue taking their ADHD medication in a safe manner while breastfeeding and during pregnancy. This has led to an increasing number of patients opt to do this and, in consultation with their physician, they have found that the benefits of maintaining their current medication outweigh any potential risks.

Women who suffer from safest adhd medication for adults who are planning to breastfeed should seek the advice of a specialist psychiatrist before becoming pregnant. They should discuss their medication with their doctor and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help women with ADHD be aware of their symptoms and the underlying disorder, learn about available treatment options and reinforce existing strategies for coping. This should include an approach that is multidisciplinary, including the GP, obstetricians and psychiatry. Counselling for pregnancy should include the discussion of a plan for management for both the mother and child, and monitoring for signs of deterioration, and the need for adjustments to the medication regimen.